Atlas Trials

A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors

Clinical trial NCT02498613 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT02498613
Sponsor
National Cancer Institute (NCI)
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Advanced Malignant Solid NeoplasmMetastatic Lung Non-Small Cell CarcinomaMetastatic Lung Small Cell CarcinomaMetastatic Pancreatic AdenocarcinomaMetastatic Triple-Negative Breast CarcinomaPancreatic Ductal AdenocarcinomaStage III Breast Cancer AJCC v7Stage III Lung Non-Small Cell Cancer AJCC v7Stage III Lung Small Cell Carcinoma AJCC v7Stage III Pancreatic Cancer AJCC v6 and v7Stage IIIA Breast Cancer AJCC v7Stage IIIA Lung Non-Small Cell Cancer AJCC v7
Start date
2016-08-31
Primary completion
2022-06-22
Enrollment
122

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.